Segmentation of cognitive computing market by technology comprises natural language processing, automated reasoning, machine learning, and semantic analysis. Machine learning is anticipated to have the highest CAGR as it is widely used across various applications of cognitive computing and artificial intelligence. Machine learning is deployed by various industries in their operations. Cognitive computing market segmentation on industry verticals include BFSI, healthcare, construction and engineering, oil and gas, retail, education, government and defense, transportation, and others. The healthcare industry is anticipated to experience a high growth during the forecast time period as it allows doctors and specialists to have access to the data collected from disparate and exogenous sources, take informed decisions, and examine critical attributes of a patient case.

Santen Pharmaceutical Co., Ltd., the leader in ophthalmic drug development, has selected ArisGlobal to create a single global safety database and improve the efficiency and quality of their global safety vigilance processes. Santen Pharmaceutical's safety suite will include ArisGlobal's LifeSphere MultiVigilance (LSMV), LifeSphere Reporting and Analytics and LifeSphere Intake and Triage solutions to automate key safety vigilance activities, reduce costs, and increase compliance. "LSMV's advanced artificial intelligence (AI) and machine learning automates repetitive manual tasks, improving efficiency and compliance levels. Switching to LSMV makes our team dramatically more efficient," added Dr. Shimada, head of global safety vigilance at Santen Pharmaceutical. Santen joins more than 250 life science companies, including 9 regulatory authorities, who use ArisGlobal's safety, medical affairs, clinical and regulatory solutions, benefiting from rapid implementation on a multi-tenant cloud with upgrades delivered seamlessly.

As part of the agreement, BioClinica becomes ArisGlobal's preferred partner in business process consulting and change management as sponsors implement or upgrade ARISg, ArisGlobal's pharmacovigilance and clinical safety system. The cloud-based solution helps facilitate drug development and regulatory compliance throughout the entire product life cycle. "We decided to partner with ArisGlobal because we saw the opportunity to offer a continuum of pharmacovigilance services that can fit the needs of sponsors and CROs as those needs change, whether sponsors are growing, merging, experiencing a surge or a drop in safety events," Mukhtar Ahmed, BioClinica President eHealth Solutions, told Outsourcing-Pharma.com. "In the same way that therapies are moving from a'one size fits all' model, so is our offering model." According to the company, the partners are currently working to develop ArisGlobal's next generation of products, which will combine medical knowledge with technologies derived from such areas as artificial intelligence, machine learning, and natural language processing.

As part of the agreement, BioClinica becomes ArisGlobal's preferred partner in business process consulting and change management as sponsors implement or upgrade ARISg, ArisGlobal's pharmacovigilance and clinical safety system. The cloud-based solution helps facilitate drug development and regulatory compliance throughout the entire product life cycle. "We decided to partner with ArisGlobal because we saw the opportunity to offer a continuum of pharmacovigilance services that can fit the needs of sponsors and CROs as those needs change, whether sponsors are growing, merging, experiencing a surge or a drop in safety events," Mukhtar Ahmed, BioClinica President eHealth Solutions, told Outsourcing-Pharma.com. "In the same way that therapies are moving from a'one size fits all' model, so is our offering model." According to the company, the partners are currently working to develop ArisGlobal's next generation of products, which will combine medical knowledge with technologies derived from such areas as artificial intelligence, machine learning, and natural language processing.